| 标题 |
Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study |
| 网址 | |
| DOI |
10.1182/blood-2021-155068
doi
|
| 其它 |
期刊:Blood 作者:Michael R. Bishop; Michael Dickinson; Duncan Purtill; Pere Barba; Armando Santoro; et al 出版日期:2021-12-04 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)